NATCO Pharma Limited (NATCOPHARM.BO)
INR 1475.25
(2.03%)
INR 1475.25
(2.03%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 25.73 Billion INR | 31.72% |
| 2022 | 19.51 Billion INR | 59.51% |
| 2021 | 12.23 Billion INR | 13.03% |
| 2020 | 10.82 Billion INR | -21.44% |
| 2019 | 13.77 Billion INR | -11.26% |
| 2018 | 15.52 Billion INR | -5.77% |
| 2017 | 16.47 Billion INR | 26.65% |
| 2016 | 13.01 Billion INR | 79.78% |
| 2015 | 7.23 Billion INR | 35.17% |
| 2014 | 5.35 Billion INR | 17.34% |
| 2013 | 4.56 Billion INR | 21.85% |
| 2012 | 3.74 Billion INR | 28.07% |
| 2011 | 2.92 Billion INR | 19.06% |
| 2010 | 2.45 Billion INR | -29.72% |
| 2009 | 3.49 Billion INR | -2.71% |
| 2008 | 3.59 Billion INR | 50.97% |
| 2007 | 2.37 Billion INR | 52.59% |
| 2006 | 1.55 Billion INR | 66.74% |
| 2005 | 935.05 Million INR | 140.84% |
| 2004 | 388.24 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 9.96 Billion INR | 36.91% |
| 2023 Q3 | 5.96 Billion INR | -26.88% |
| 2023 Q1 | 9.44 Billion INR | 84.8% |
| 2023 Q2 | 8.15 Billion INR | -13.65% |
| 2023 Q4 | 7.27 Billion INR | 22.02% |
| 2023 FY | 25.7 Billion INR | 31.72% |
| 2022 Q3 | 3.77 Billion INR | 15.57% |
| 2022 Q4 | 5.11 Billion INR | 35.53% |
| 2022 FY | 19.51 Billion INR | 59.51% |
| 2022 Q1 | 7.36 Billion INR | 426.36% |
| 2022 Q2 | 3.26 Billion INR | -55.72% |
| 2021 Q4 | 1.4 Billion INR | -70.05% |
| 2021 Q1 | 3.31 Billion INR | 282.48% |
| 2021 FY | 12.23 Billion INR | 13.03% |
| 2021 Q2 | 2.84 Billion INR | -14.04% |
| 2021 Q3 | 4.67 Billion INR | 64.21% |
| 2020 Q1 | 3.84 Billion INR | 88.2% |
| 2020 Q2 | 6.07 Billion INR | 57.95% |
| 2020 Q3 | 2.72 Billion INR | -55.2% |
| 2020 Q4 | -1.81 Billion INR | -166.7% |
| 2020 FY | 10.82 Billion INR | -21.44% |
| 2019 Q3 | 3.9 Billion INR | 6.6% |
| 2019 FY | 13.77 Billion INR | -11.26% |
| 2019 Q4 | 2.04 Billion INR | -47.71% |
| 2019 Q2 | 3.66 Billion INR | -11.96% |
| 2019 Q1 | 4.16 Billion INR | 67.66% |
| 2018 Q4 | 2.48 Billion INR | -45.03% |
| 2018 Q3 | 4.51 Billion INR | 0.69% |
| 2018 Q2 | 4.48 Billion INR | -0.6% |
| 2018 FY | 15.52 Billion INR | -5.77% |
| 2018 Q1 | 4.51 Billion INR | -30.01% |
| 2017 FY | 16.47 Billion INR | 26.65% |
| 2017 Q1 | 3.18 Billion INR | -28.78% |
| 2017 Q4 | 6.44 Billion INR | 29.9% |
| 2017 Q2 | 3.13 Billion INR | -1.54% |
| 2017 Q3 | 4.96 Billion INR | 58.19% |
| 2016 Q4 | 4.47 Billion INR | -3.64% |
| 2016 Q1 | 2.32 Billion INR | -21.08% |
| 2016 Q3 | 4.64 Billion INR | 67.96% |
| 2016 Q2 | 2.76 Billion INR | 18.92% |
| 2016 FY | 13.01 Billion INR | 79.78% |
| 2015 Q4 | 2.94 Billion INR | 60.97% |
| 2015 FY | 7.23 Billion INR | 35.17% |
| 2015 Q3 | 1.83 Billion INR | 8.21% |
| 2015 Q2 | 1.69 Billion INR | 15.97% |
| 2015 Q1 | 1.45 Billion INR | 0.85% |
| 2014 Q4 | 1.44 Billion INR | 19.3% |
| 2014 Q2 | 1.44 Billion INR | 15.88% |
| 2014 Q1 | 1.24 Billion INR | 11.64% |
| 2014 FY | 5.35 Billion INR | 17.34% |
| 2014 Q3 | 1.21 Billion INR | -16.2% |
| 2013 Q2 | 1.05 Billion INR | -4.36% |
| 2013 Q3 | 1.28 Billion INR | 22.1% |
| 2013 FY | 4.56 Billion INR | 21.85% |
| 2013 Q1 | 1.09 Billion INR | 15.98% |
| 2013 Q4 | 1.11 Billion INR | -12.83% |
| 2012 Q1 | 813 Million INR | 15.55% |
| 2012 FY | 3.74 Billion INR | 28.07% |
| 2012 Q2 | 1.02 Billion INR | 26.17% |
| 2012 Q4 | 947.02 Million INR | 4.1% |
| 2012 Q3 | 909.7 Million INR | -11.32% |
| 2011 Q3 | 776.9 Million INR | -1.43% |
| 2011 FY | 2.92 Billion INR | 19.06% |
| 2011 Q2 | 788.2 Million INR | 0.0% |
| 2011 Q4 | 703.56 Million INR | -9.44% |
| 2010 FY | 2.45 Billion INR | -29.72% |
| 2009 FY | 3.49 Billion INR | -2.71% |
| 2008 FY | 3.59 Billion INR | 50.97% |
| 2007 FY | 2.37 Billion INR | 52.59% |
| 2006 FY | 1.55 Billion INR | 66.74% |
| 2005 FY | 935.05 Million INR | 140.84% |
| 2004 FY | 388.24 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Ajanta Pharma Limited | 21.06 Billion INR | -22.18% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | -1553.419% |
| Sigachi Industries Limited | 2 Billion INR | -1185.333% |
| Bal Pharma Limited | 770.19 Million INR | -3241.491% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | -315.475% |
| Medico Remedies Limited | 262.14 Million INR | -9717.505% |
| Lasa Supergenerics Limited | 121.02 Million INR | -21164.15% |
| Venus Remedies Limited | 2.18 Billion INR | -1079.152% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 4372.202% |
| Alpa Laboratories Limited | 188.89 Million INR | -13524.5% |
| Nectar Lifesciences Limited | 2.97 Billion INR | -765.931% |
| Shilpa Medicare Limited | 3.54 Billion INR | -625.599% |
| Aarti Drugs Limited | 8.31 Billion INR | -209.468% |
| Lupin Limited | 123.71 Billion INR | 79.198% |
| Aurobindo Pharma Limited | 154.68 Billion INR | 83.362% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 79.446% |
| Windlas Biotech Limited | 1.33 Billion INR | -1822.318% |
| Suven Life Sciences Limited | -200.79 Million INR | 12916.925% |
| Eris Lifesciences Limited | 10.42 Billion INR | -146.826% |
| Valiant Laboratories Limited | -60.66 Million INR | 42523.843% |
| J. B. Chemicals & Pharmaceuticals Limited | 22.69 Billion INR | -13.375% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | -2888.388% |
| Ipca Laboratories Limited | 29.8 Billion INR | 13.666% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -596.427% |
| Achyut Healthcare Limited | 4.86 Million INR | -529338.387% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 90.044% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -1648.6% |
| RPG Life Sciences Limited | 2.48 Billion INR | -936.488% |
| Mankind Pharma Limited | 44.52 Billion INR | 42.193% |
| Laurus Labs Limited | 24.62 Billion INR | -4.532% |
| Piramal Pharma Limited | 24.47 Billion INR | -5.17% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -2630.903% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 44.958% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 3.901% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 62.885% |
| Unichem Laboratories Limited | 4.86 Billion INR | -429.011% |
| Sequent Scientific Limited | 2.97 Billion INR | -763.992% |
| Novartis India Limited | 1.32 Billion INR | -1839.558% |
| Wanbury Limited | 1.73 Billion INR | -1387.077% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -524.164% |
| Wockhardt Limited | 16.24 Billion INR | -58.473% |
| Themis Medicare Limited | 1.5 Billion INR | -1611.279% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -3843.671% |
| Jubilant Pharmova Limited | 19.64 Billion INR | -31.019% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -106.998% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 84.27% |
| Divi's Laboratories Limited | 32.44 Billion INR | 20.666% |
| Gufic Biosciences Limited | 4.16 Billion INR | -517.51% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | -461.823% |
| Ind-Swift Limited | 2.17 Billion INR | -1084.609% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -345.152% |
| FDC Limited | 8.33 Billion INR | -208.78% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | -13253.604% |
| Granules India Limited | 16.79 Billion INR | -53.197% |
| Medicamen Biotech Limited | 495.49 Million INR | -5093.998% |
| Alkem Laboratories Limited | 52.29 Billion INR | 50.789% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -313.583% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | -176419.407% |
| Brooks Laboratories Limited | 65.62 Million INR | -39119.75% |
| Megasoft Limited | 342.07 Million INR | -7423.584% |
| ZIM Laboratories Limited | 1.26 Billion INR | -1931.436% |
| Strides Pharma Science Limited | 14.38 Billion INR | -78.87% |
| Neuland Laboratories Limited | 8.24 Billion INR | -212.033% |
| Morepen Laboratories Limited | 6.16 Billion INR | -317.705% |
| Hikal Limited | 3.14 Billion INR | -718.815% |
| Indoco Remedies Limited | 6.04 Billion INR | -326.0% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -341.338% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -4047.777% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | -3557.734% |
| Hester Biosciences Limited | 1.27 Billion INR | -1920.649% |